Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity
- 10 September 2003
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (21), 3797-3800
- https://doi.org/10.1016/j.bmcl.2003.07.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Targeting Protein Kinases for Bone Disease: Discovery and Development of Src InhibitorsCurrent Pharmaceutical Design, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Role of Src in Signal Transduction PathwaysBiochemical Society Transactions, 2002
- Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase ActivityJournal of Medicinal Chemistry, 2001
- Oncogenic kinase signallingNature, 2001
- Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitrilesJournal of Medicinal Chemistry, 2001
- SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor SignalingMolecular and Cellular Biology, 2000
- Inhibitors of Src tyrosine kinase: the preparation and structure–activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolinesBioorganic & Medicinal Chemistry Letters, 2000
- Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitorsBiochemical Pharmacology, 2000
- A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivoBone, 1999